Reference method for measurement of the hepatic iron concentration
Reproducibility of liver iron concentration measured on a biopsy sample: A validation study in vivo
Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine
Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia
Extramedullary Waldenström macroglobulinemia
Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib
Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: The missing piece in the puzzle of their increased cardiovascular risk?
Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria
Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia
Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia
The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma
Health-related quality of life in children with sickle cell anemia: Impact of blood transfusion therapy
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation
Clinical phenotype in heterozygote and biallelic Bernard-Soulier syndrome—A case control study
How I treat newly diagnosed chronic myeloid leukemia in 2015
Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management
Hemoglobin C disease
Anticoagulation management of left ventricular assist devices
Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia
Comparison of 60 or 90 mg/m2 of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics
Red blood cell nitric oxide synthase activation is increased in patients with sickle cell hemoglobin C disease
Chronic physical activity limits blood rheology alterations in transgenic SAD mice